Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection

被引:0
|
作者
Petrova, N. V. [1 ,3 ]
Emelyanova, A. G. [1 ,3 ]
Tarasov, S. A. [1 ,3 ]
Glubokova, E. A. [2 ]
Kartashova, N. P. [2 ]
机构
[1] Res Inst Gen Pathol & Pathophysiol, Moscow, Russia
[2] II Mechnikov Res Inst Vaccines & Sera, Moscow, Russia
[3] LLC MATERIA MEDICA HOLDING, Moscow, Russia
关键词
influenza A infection; technologically processed antibodies; CD4; receptor; Ergoferon; Raphamin; EFFICACY; OSELTAMIVIR; ERGOFERON; SAFETY;
D O I
10.1007/s10517-023-05683-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The antiviral activity of technologically processed antibodies to CD4 receptor was evaluated a model of sublethal A/California/04/2009 (H1N1)pdm09-induced influenza infection in female BALB/c mice. The technologically processed antibodies increased animal survival rate by 50% in comparison with the placebo group (p < 0.05), which correlated with significant inhibition of virus replication in the lungs (p < 0.05). The reference drug Tamiflu increased mouse survival rate (by 47%), decreased the virus titer in the lungs, and prevented body weight loss (p < 0.05 in comparison with the placebo group by all parameters). The intrinsic protective activity of technologically processed antibodies to CD4 receptor was demonstrated, which manifested in a decrease in viral load in the lower respiratory tract and an increase in the survival rate.
引用
收藏
页码:250 / 253
页数:4
相关论文
共 50 条
  • [31] A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity
    Oh, Ding Yuan
    Barr, Ian G.
    Hurt, Aeron C.
    PLOS ONE, 2015, 10 (03):
  • [32] CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-Induced Antibodies
    Ding, Shilei
    Gasser, Romain
    Gendron-Lepage, Gabrielle
    Medjahed, Halima
    Tolbert, William D.
    Sodroski, Joseph
    Pazgier, Marzena
    Finzi, Andres
    JOURNAL OF VIROLOGY, 2019, 93 (22)
  • [33] Long-term treatment of pigs with low doses of monoclonal antibodies against porcine CD4 and CD8 antigens
    Lohse, L
    Nielsen, J
    Eriksen, L
    APMIS, 2006, 114 (01) : 23 - 31
  • [34] Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection
    Fox, Annette
    Le Quynh Mai
    Le Thi Thanh
    Wolbers, Marcel
    Nguyen Le Khanh Hang
    Pham Quang Thai
    Nguyen Thi Thu Yen
    Le Nguyen Minh Hoa
    Bryant, Juliet E.
    Tran Nhu Duong
    Dang Dinh Thoang
    Barr, Ian G.
    Wertheim, Heiman
    Farrar, Jeremy
    Nguyen Tran Hien
    Horby, Peter
    JOURNAL OF INFECTION, 2015, 70 (02) : 187 - 196
  • [35] Identification of a CD4 variant in Microminipigs not detectable with available anti-CD4 monoclonal antibodies
    Matsubara, Tatsuya
    Nishii, Naohito
    Takashima, Satoshi
    Takasu, Masaki
    Imaeda, Noriaki
    Aiki-Oshimo, Kayo
    Yamazoe, Kazuaki
    Kametani, Yoshie
    Ando, Asako
    Kitagawa, Hitoshi
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2015, 168 (3-4) : 176 - 183
  • [36] Enhancing and inhibitory motifs regulate CD4 activity
    Lee, Mark S.
    Tuohy, Peter J.
    Kim, Caleb Y.
    Lichauco, Katrina
    Parrish, Heather L.
    Van Doorslaer, Koenraad
    Kuhns, Michael S.
    McLaughlin, Richard N.
    ELIFE, 2022, 11
  • [37] Dysregulation of the interleukin-2 receptor α- and β-chain expression in CD4 and CD8 T cells in HIV infection
    Johnson, N
    Parkin, JM
    CYTOMETRY, 1997, 30 (06): : 289 - 295
  • [38] Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor downmodulating activity
    Vermeire, Kurt
    Lisco, Andrea
    Grivel, Jean-Charles
    Scarbrough, Emily
    Dey, Kaka
    Duffy, Noah
    Margolis, Leonid
    Bell, Thomas W.
    Schols, Dominique
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (04) : 566 - 578
  • [39] Combination of an Aptamer Probe to CD4 and Antibodies for Multicolored Cell Phenotyping
    Zhang, Peng
    Zhao, Nianxi
    Zeng, Zihua
    Chang, Chung-Che
    Zu, Youli
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (04) : 586 - 593
  • [40] Inhibitory activity of antibodies against the human atrial 5-HT4 receptor
    Sallé, L
    Eftekhari, P
    Aupart, M
    Cosnay, P
    Hoebeke, J
    Argibay, JA
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (03) : 405 - 417